$1.18
0.0050.43%
Last update: 11:04 AM
15 minutes delayed
Adicet Bio
ACETNASDAQ
Adicet Bio (NASDAQ:ACET) Stock, Insider Trading Activity
Adicet Bio: Insider buying and selling updated today.
Institutional Shares Held
12.175M
Institutional Percentage Held
14.8%
| Jun 07, 2024 | Michael Kauffman | — | 0 | $1.43 | -$8.44K | GRANT | 0.00% | 5.9K | Jun 05 | View |
| Jan 26, 2024 | ORBIMED ADVISORS LLCOrbiMed Capital GP V LLCOrbiMed Capital GP VI LLCOrbiMed Genesis GP LLCOrbiMed Advisors Israel II LtdOrbiMed Israel GP II LPOrbiMed Israel GP LtdOrbiMed Israel BioFund GP Limited Partnership | — | 3.125M | $2.40 | $7.50M | BUY | ∞ | 1.902642M | Jan 25 | View |
| Jan 26, 2024 | Carl L Gordon | — | 3.125M | $2.40 | $7.50M | BUY | ∞ | 1.902642M | Jan 25 | View |
| Oct 02, 2023 | Chen Schor | PRESIDENT & CEO | -23.208K | $1.38 | -$31.94K | SELL | -10.07% | 207.185K | Sep 28 - Oct 02 | View |
| Jun 30, 2023 | STEVE DUBIN | DIRECTOR | 5K | $2.40 | $12.00K | BUY | 84.75% | 10.9K | Jun 30 | View |
| Jun 29, 2023 | Carl L Gordon | DIRECTOR | 875K | $2.09 | $1.83M | BUY | 1001.84% | 962.339K | Jun 27 | View |
| Jun 29, 2023 | ORBIMED ADVISORS LLCOrbiMed Capital GP V LLCOrbiMed Capital GP VI LLCOrbiMed Genesis GP LLCOrbiMed Advisors Israel II LtdOrbiMed Israel GP II LPOrbiMed Israel GP LtdOrbiMed Israel BioFund GP Limited PartnershipErez Chimovits | DIRECTOR | 875K | $2.09 | $1.83M | BUY | 1001.84% | 962.339K | Jun 27 | View |
| Feb 17, 2023 | Don Healey | CHIEF TECHNOLOGY OFFICER | -4.533K | $7.57 | -$34.33K | SELL | -6.38% | 66.568K | Feb 15 | View |
| Feb 14, 2023 | Don Healey | CHIEF TECHNOLOGY OFFICER | -10.467K | $7.98 | -$83.48K | SELL | -12.83% | 71.101K | Feb 10 | View |
| Nov 15, 2022 | Blake Aftab | CHIEF SCIENTIFIC OFFICER | -6.967K | $21.00 | -$146.31K | SELL | -19.81% | 28.209K | Nov 10 | View |
| Nov 15, 2022 | Chen Schor | PRESIDENT & CEO | -39.955K | $20.30 | -$811.24K | SELL | -42.79% | 53.424K | Nov 10 | View |
| Nov 09, 2022 | Chen Schor | PRESIDENT & CEO | -30K | $19.05 | -$571.49K | SELL | -13.96% | 184.848K | Nov 07 | View |
| Nov 04, 2022 | Chen Schor | PRESIDENT & CEO | -25.313K | $18.04 | -$456.72K | SELL | -10.54% | 214.848K | Nov 02 - Nov 03 | View |
| Oct 21, 2022 | Blake Aftab | CHIEF SCIENTIFIC OFFICER | -8.067K | $16.27 | -$131.25K | SELL | -18.66% | 35.176K | Oct 19 | View |
| Oct 14, 2022 | Blake Aftab | CHIEF SCIENTIFIC OFFICER | -6.191K | $11.61 | -$126.64K | SELL | -12.52% | 43.243K | Oct 12 - Oct 13 | View |
| Sep 16, 2022 | Chen Schor | PRESIDENT & CEO | -952 | $18.00 | -$17.14K | SELL | -0.36% | 261.449K | Sep 14 | View |
| Sep 13, 2022 | Chen Schor | PRESIDENT & CEO | -78.412K | $16.80 | -$1.32M | SELL | -23.01% | 262.401K | Sep 09 - Sep 13 | View |
| Aug 05, 2022 | Blake Aftab | CHIEF SCIENTIFIC OFFICER | -6.968K | $18.00 | -$125.42K | SELL | -15.17% | 38.967K | Aug 03 | View |
| Aug 03, 2022 | Blake Aftab | CHIEF SCIENTIFIC OFFICER | -6.968K | $16.64 | -$115.95K | SELL | -13.17% | 45.935K | Aug 01 | View |
| Jul 07, 2022 | Blake Aftab | CHIEF SCIENTIFIC OFFICER | -1.363K | $14.50 | -$19.76K | SELL | -2.51% | 52.903K | Jul 05 | View |
| Apr 05, 2022 | Francesco Galimi | SVP & CHIEF MEDICAL OFFICER | 0 | $15.51 | -$171.15K | SELL-OPTIONS | 0.00% | 59.917K | Apr 01 - Apr 04 | View |
| Mar 11, 2022 | Aya Jakobovits | DIRECTOR | -4K | $14.00 | -$56.00K | SELL | -0.80% | 494.421K | Mar 09 | View |
| Feb 17, 2022 | Aya Jakobovits | DIRECTOR | -4K | $14.83 | -$59.33K | SELL | -0.80% | 496.421K | Feb 16 | View |
| Feb 14, 2022 | Aya Jakobovits | DIRECTOR | -24K | $16.51 | -$396.16K | SELL | -4.59% | 498.421K | Jan 03 - Feb 09 | View |
| Dec 10, 2021 | Andrew Sinclair | DIRECTOR | 500K | $14.00 | $7.00M | BUY | 30.47% | 2.140721M | Dec 08 | View |
| Jun 21, 2021 | Chen Schor | PRESIDENT & CEO | -16.466K | $10.53 | -$173.44K | SELL | -15.49% | 89.836K | Jun 16 | View |
| Jun 17, 2021 | Aya Jakobovits | DIRECTOR | -3.847K | $11.16 | -$42.92K | SELL | -1.08% | 351.682K | Jun 15 | View |
| Jun 07, 2021 | Chen Schor | PRESIDENT & CEO | -16.466K | $12.06 | -$198.50K | SELL | -14.28% | 98.818K | Jun 03 | View |
| May 21, 2021 | Chen Schor | PRESIDENT & CEO | -16.466K | $13.45 | -$221.44K | SELL | -13.25% | 107.8K | May 19 | View |
| May 20, 2021 | Aya Jakobovits | DIRECTOR | -8K | $14.09 | -$112.75K | SELL | -2.21% | 353.605K | May 18 - May 20 | View |
| May 14, 2021 | Aya Jakobovits | DIRECTOR | -10K | $13.23 | -$132.33K | SELL | -2.72% | 357.605K | May 12 | View |
| May 07, 2021 | Chen Schor | PRESIDENT & CEO | -16.466K | $14.22 | -$234.22K | SELL | -12.36% | 116.782K | May 05 | View |
| Apr 22, 2021 | Chen Schor | PRESIDENT AND CEO | -16.466K | $12.01 | -$197.68K | SELL | -13.58% | 104.777K | Apr 20 | View |
| Apr 08, 2021 | Chen Schor | PRESIDENT AND CEO | -16.466K | $13.04 | -$214.70K | SELL | -12.79% | 112.261K | Apr 06 | View |
| Apr 01, 2021 | Chen Schor | PRESIDENT AND CEO | -16.466K | $12.85 | -$211.64K | SELL | -12.09% | 119.745K | Mar 30 | View |
| Mar 18, 2021 | Chen Schor | PRESIDENT AND CEO | -16.466K | $15.34 | -$252.56K | SELL | -11.46% | 127.229K | Mar 16 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.